The Medical Letter on Drugs and Therapeutics
Paxlovid for Treatment of COVID-19
January 24, 2022 (Issue: 1642)On December 22, 2021, the FDA issued an Emergency Use Authorization (EUA) for the investigational antiviral drug nirmatrelvir copackaged with the HIV-1 protease inhibitor ritonavir (Paxlovid – Pfizer) for oral treatment of mild to moderate...more
- FDA. Fact sheet for health care providers: Emergency Use Authorization for Paxlovid. December 22, 2021. Available at: https://bit.ly/3sTNGqh. Accessed January 6, 2022.
- FDA. Fact sheet for health care providers: Emergency Use Authorization for molnupiravir. December 23, 2021. Available at: https://bit.ly/3FSVSe2. Accessed January 6, 2022.
- Remdesivir (Veklury) for Covid-19. Med Lett Drugs Ther 2020; 62:186.
- Inhibitors and inducers of CYP enzymes, P-glycoprotein, and other transporters. Med Lett Drugs Ther 2021 October 20 (epub). Available at: medicalletter.org/downloads/CYP_PGP_Tables.pdf.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.